Alloimmunization to the D antigen by a patient with weak D type 21

Area of Science:

• Immunology
• Genetics
• Transfusion Medicine

Background:

• Individuals with weak D phenotypes typically do not produce anti-D alloantibodies.
• The D antigen is a key component of the Rh blood group system, crucial for blood transfusion compatibility.
• Weak D variants, such as type 21, present unique challenges in serological and molecular testing.

Observation:

• A D+ patient with myelodysplasia developed a persistent anti-D alloantibody.
• Molecular analysis revealed the patient possessed the weak D type 21 (938C > T) RHD allele.
• This alloantibody was detectable for nine months.

Findings:

• Weak D type 21 can elicit an anti-D immune response in D+ individuals.
• The presence of anti-D antibodies in D+ patients can be linked to specific RHD gene variants.
• Nonself epitopes on the wild-type D antigen may trigger antibody production in certain weak D phenotypes.

Implications:

• Transfusion protocols may need refinement for patients with weak D phenotypes, particularly type 21.
• Accurate RHD gene molecular testing is vital for identifying individuals at risk of alloimmunization.
• Understanding rare RHD variants improves transfusion safety and management of patients requiring blood products.